Eva Turgonyi

444 total citations
12 papers, 190 citations indexed

About

Eva Turgonyi is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Eva Turgonyi has authored 12 papers receiving a total of 190 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 5 papers in Endocrinology, Diabetes and Metabolism and 2 papers in Surgery. Recurrent topics in Eva Turgonyi's work include Heart Failure Treatment and Management (7 papers), Cardiac pacing and defibrillation studies (4 papers) and Cardiovascular Function and Risk Factors (4 papers). Eva Turgonyi is often cited by papers focused on Heart Failure Treatment and Management (7 papers), Cardiac pacing and defibrillation studies (4 papers) and Cardiovascular Function and Risk Factors (4 papers). Eva Turgonyi collaborates with scholars based in United Kingdom, Germany and United States. Eva Turgonyi's co-authors include Peter Bramlage, Michael Böhm, Faı̈ez Zannad, Stephan H. Schirmer, Adriaan A. Voors, Jean‐Marie Ketelslegers, Ulrich Tebbe, Ashok Kumar, Patrick Rossignol and Wilfred Lim and has published in prestigious journals such as European Journal of Heart Failure, Journal of Cardiac Failure and Heart Failure Reviews.

In The Last Decade

Eva Turgonyi

12 papers receiving 179 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Turgonyi United Kingdom 9 130 48 24 24 22 12 190
John Molvin Sweden 11 133 1.0× 20 0.4× 33 1.4× 16 0.7× 42 1.9× 23 284
Chirag Ram United States 7 101 0.8× 36 0.8× 52 2.2× 15 0.6× 42 1.9× 15 245
Hiroyoshi Segawa Japan 9 110 0.8× 23 0.5× 54 2.3× 8 0.3× 25 1.1× 38 268
Ahmed Mustafa Rashid Pakistan 8 69 0.5× 54 1.1× 13 0.5× 8 0.3× 27 1.2× 34 192
Parminder S Chaggar United Kingdom 8 119 0.9× 62 1.3× 23 1.0× 31 1.3× 68 3.1× 15 253
Lidia Cobos-Palacios Spain 9 41 0.3× 76 1.6× 11 0.5× 9 0.4× 41 1.9× 20 225
Paolo Poisa Italy 4 322 2.5× 59 1.2× 46 1.9× 10 0.4× 38 1.7× 4 368
Lida Feyz Netherlands 10 181 1.4× 33 0.7× 14 0.6× 25 1.0× 26 1.2× 27 232
Mahboob Rahman United States 5 85 0.7× 26 0.5× 20 0.8× 7 0.3× 25 1.1× 10 143
Jurij Dobovišek Italy 6 273 2.1× 43 0.9× 15 0.6× 6 0.3× 52 2.4× 9 329

Countries citing papers authored by Eva Turgonyi

Since Specialization
Citations

This map shows the geographic impact of Eva Turgonyi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Turgonyi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Turgonyi more than expected).

Fields of papers citing papers by Eva Turgonyi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Turgonyi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Turgonyi. The network helps show where Eva Turgonyi may publish in the future.

Co-authorship network of co-authors of Eva Turgonyi

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Turgonyi. A scholar is included among the top collaborators of Eva Turgonyi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Turgonyi. Eva Turgonyi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Chioncel, Ovidiu, Jelena Čelutkienė, Jan Bělohlávek, et al.. (2024). Heart Failure Care in the Central and Eastern Europe and Baltic Region: Status, Barriers, and Routes to Improvement. ESC Heart Failure. 11(4). 1861–1874. 8 indexed citations
2.
Ferreira, João Pedro, Kévin Duarte, Gilles Montalescot, et al.. (2017). Effect of eplerenone on extracellular cardiac matrix biomarkers in patients with acute ST-elevation myocardial infarction without heart failure: insights from the randomized double-blind REMINDER Study. Clinical Research in Cardiology. 107(1). 49–59. 17 indexed citations
3.
Chin, Ken Lee, Timothy Collier, Bertram Pitt, et al.. (2016). Aspirin does not Reduce the Clinical Benefits of the Mineralocorticoid Receptor Antagonist Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms: An Analysis of the EMPHASIS-HF Study. European Journal of Heart Failure. 18(9). 1175–1181. 9 indexed citations
4.
5.
Beygui, Farzin, Manuel Anguita, Ulrich Tebbe, et al.. (2015). A real-world perspective on the prevalence and treatment of heart failure with a reduced ejection fraction but no specific or only mild symptoms. Heart Failure Reviews. 20(5). 545–552. 9 indexed citations
6.
Tebbe, Ulrich, et al.. (2014). Registry in Germany focusing on level-specific and evidence-based decision finding in the treatment of heart failure: REFLECT-HF. Clinical Research in Cardiology. 103(8). 665–673. 25 indexed citations
7.
Ukena, Christian, Daniela Dobre, Felix Mahfoud, et al.. (2012). Hypo- and Hyperglycemia Predict Outcome in Patients With Left Ventricular Dysfunction After Acute Myocardial Infarction: Data From EPHESUS. Journal of Cardiac Failure. 18(6). 439–445. 28 indexed citations
8.
Bramlage, Peter, Eva Turgonyi, & Gilles Montalescot. (2011). Aldosterone blockade: current research and future trends. European Heart Journal Supplements. 13(Suppl B). B46–B50. 7 indexed citations
9.
Böhm, Michael, Adriaan A. Voors, Jean‐Marie Ketelslegers, et al.. (2011). Biomarkers: optimizing treatment guidance in heart failure. Clinical Research in Cardiology. 100(11). 973–981. 39 indexed citations
10.
Deedwania, Prakash, Bertram Pitt, Ravi V. Desai, et al.. (2010). Aldosterone Antagonism With Eplerenone Does Not Adversely Affect Plasma Glucose Levels in Patients With Diabetes Mellitus: Findings From a Post Hoc Analysis of the EPHESUS Trial. 1 indexed citations
11.
Buckley, Brendan M., et al.. (2009). Blood Pressure Control in Hypertensive Patients in Irish Primary Care Practices. Journal of Clinical Hypertension. 11(8). 432–440. 10 indexed citations
12.
Díaz‐Mitoma, Francisco, et al.. (2003). Clinical Improvement in Chronic Fatigue Syndrome Is Associated with Enhanced Natural Killer Cell-Mediated Cytotoxicity: The Results of a Pilot Study with Isoprinosine®. Journal of Chronic Fatigue Syndrome. 11(2). 71–95. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John Molvin Breakdown of academic impact, for papers by Chirag Ram Breakdown of academic impact, for papers by Hiroyoshi Segawa Breakdown of academic impact, for papers by Ahmed Mustafa Rashid Breakdown of academic impact, for papers by Parminder S Chaggar Breakdown of academic impact, for papers by Lidia Cobos-Palacios Breakdown of academic impact, for papers by Paolo Poisa Breakdown of academic impact, for papers by Lida Feyz Breakdown of academic impact, for papers by Mahboob Rahman Breakdown of academic impact, for papers by Jurij Dobovišek
Rankless by CCL
2026